“…The paper by Bresadola et al [ 8 ] using a case of synchronous cancers shows how the integration between genomic and transcriptomic analyses may contribute to a personalized revision of the therapeutic management, dissecting, and profiling of a tumor by germline variants, the immunological microenvironment, and cellular clones.…”